T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: International Journal of Molecular Sciences 22.16 (2021): 8679.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2021
- Urheber
-
Gehrcken, Laura
Sauerer, Tatjana
Schaft, Niels
Dörrie, Jan
- DOI
-
10.3390/ijms22168679
- URN
-
urn:nbn:de:bvb:29-opus4-194621
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gehrcken, Laura
- Sauerer, Tatjana
- Schaft, Niels
- Dörrie, Jan
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2021
Ähnliche Objekte (12)
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
T-cell receptor avidity of polyclonal CD8+ T-cell populations
Human T-cell clones
CAR T-Cell therapy
Renal cell carcinoma with sarcomatoid features: finally new therapeutic hope?
The immunopeptidomic landscape of clear cell renal cell carcinoma : identification and characterization of T-cell epitopes for immunotherapeutic approaches
The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia
Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine
Human T-cell leukemia virus
Stochastic T-cell fate decisions
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
T-cell receptor avidity of polyclonal CD8+ T-cell populations
Human T-cell clones
CAR T-Cell therapy
Renal cell carcinoma with sarcomatoid features: finally new therapeutic hope?
The immunopeptidomic landscape of clear cell renal cell carcinoma : identification and characterization of T-cell epitopes for immunotherapeutic approaches
The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia
Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine
Human T-cell leukemia virus
Stochastic T-cell fate decisions
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
T-cell receptor avidity of polyclonal CD8+ T-cell populations
Human T-cell clones
CAR T-Cell therapy
Renal cell carcinoma with sarcomatoid features: finally new therapeutic hope?
The immunopeptidomic landscape of clear cell renal cell carcinoma : identification and characterization of T-cell epitopes for immunotherapeutic approaches
The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia
Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine
Human T-cell leukemia virus